Selected scientific papers
This section contains a selection of Dr. Breggin's scientific articles spanning 1964 to the present. They can be arranged chronologically in order to facilitate an overview of his work over the years.
 
 

DocumentsDate added

Order by : Name | Date | Hits | [ Descendent ]
file icon Selected chapters from The Heart of Being Helpful (1997) 01/01/1997
Selected Chapters from The Heart of Being Helpful: Empathy and the Creation of a Healing Presence . New York: Springer Publishing Company, 1997.
file icon The psychiatric drugging of toddlers 02/01/2000
"The Psychiatric Drugging of Toddlers." Ethical Human Sciences and Services, 2: 83-86, 2000.
file icon Psychostimulants in the treatment of children diagnosed with ADHD (1999) 06/01/1999
"Psychostimulants in the Treatment of Children Diagnosed with ADHD: Risks and Mechanism of Action." International Journal of Risk and Safety in Medicine, 12 (1), 3-35, 1999.
file icon Fluvoxamine as a cause of stimulation, mania and aggression ( 2002) 02/01/2002
"Fluvoxamine as a Cause of Stimulation, Mania, and Aggression with a Critical Analysis of the FDA-Approved Label." International Journal of Risk and Safety in Medicine, 14: 71-86, 2002. Originally published in Ethical Human Sciences and Services, 4:211-227, 2002.
file icon Psychiatry's reliance on coercion (1999) 02/01/1999
"Psychiatry's Reliance on Coercion." Ethical Human Sciences and Services, 1:115-118, 1999.
file icon The sedative-like effects of epinephrine 01/03/1970
"The Sedative-like Effect of Epinephrine." Archives of General Psychiatry 12:255-259, 1965.
file icon Should the use of neuroleptics be severely limited? (1994) 02/01/1996
"Should the Use of Neuroleptics Be Severely Limited?" In S.A Kirk and Susan D. Einbinder P (ed): Controversial Issues in Mental Health. Boston: Allyan and Bacon, 1994, pp 146-152. Reprinted in Changes: An International Journal of Psychology and Psychotherapy 14:62-66 March 1996.
file icon Empathic self-transformation in therapy (2002) 01/01/2002
"Empathic Self-Transformation in Therapy." Excerpt from Dimensions of Empathic Therapy , P. Breggin, G. Breggin and F. Bemak, editors. Springer Publishing Company, pp. 177 - 189, 2002.
file icon Psychopharmacology and human values (2003) 01/01/2003
"Psychopharmacology and Human Values." Journal of Humanistic Psychology, 43: 34-49, 2003.
file icon Psychiatric drug-induced Chronic Brain Impairment (CBI) 01/25/2012
Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medication. International Journal of Risk & Safety in Medicine, 23: 193-200.
 
Peter R. Breggin, MD
 
Abstract: Understanding the hazards associated with long-term exposure to psychiatric drugs is very important but rarely emphasized in the scientific literature and clinical practice. Drawing on the scientific literature and clinical experience, the author describes the syndrome of Chronic Brain Impairment (CBM) which can be caused by any trauma to the brain including Traumatic Brain Injury (TBI), electroconvulsive therapy (ECT), and long-term exposure to psychiatric medications. Knowledge of the syndrome should enable clinicians to more easily identify long-term adverse effects caused by psychiatric drugs while enabling researchers to approach the problem with a more comprehensive understanding of the common elements of brain injury as they are manifested after long-term exposure to psychiatric medications. Treatment options are also discussed.
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>
Results 41 - 50 of 69

 

WARNING!

Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems. In short, it is not only dangerous to start taking psychiatric drugs, it can also be dangerous to stop them. Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision. Methods for safely withdrawing from psychiatric drugs are discussed in Dr. Breggin's new book, Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients, and Their Families.